Zelira Therapeutics Ltd (ZLDAF)

[dhbuzz]

Up slightly in Australia today.



https://www.wsj.com/market-data/quotes/AU/XASX/ZLD/company-people

[nonameface13]

Thanks - unfort. I've been fully invested into this and XXII for 2 years plus... I wish I could get into XXII at current price point... a steal IMO but check them out... GL... risky but high reward...

I believe both will finally explode before the end of this year... GL!

[dhbuzz]

I agree,and see your point.Its going to be good to get the end of march data in and finalized,and then move forward with seeing what more is going to be required to FDA standards and ok.In the mean time if the product can get intothe market before the FDA approval im for it,I certainly ,would have no problem with Zelira doing what GWPH did.Im in another stock
ZYNE,working in this field,if you don't know of them check them out.Could also be a big gainer,and highly ranked with Zacks,and impressive target estimate.

[nonameface13]

I just mean to bring true authority to the medicine... FDA seal of approval is key... no?

Yes we can market and make $... but... let's become like GWPH

[dhbuzz]

So,Im a bit confused,my interpretation of the last trial results for

insomnia would allow an opening to states with legalized med mj for Zeliras product.

"A final report from the clinical study including an analysis of a comprehensive suite of secondary endpoints will be provided by end of March 2020. These results will inform the design of any future clinical studies.
Zelira will also seek to deploy its Launch, Learn and Develop strategy to commence supply of its clinically-validated insomnia formula in countries and states where medicinal cannabis has been legalised including Australia, the USA, Germany and the United Kingdom."

[nonameface13]

Probably need FDA approval to get to boss level

[dhbuzz]

It's kind of hard to get your mind around

what Zelira may become with ZLT 101 going to market for insomnia treatment.

I know everyone's heard the stories of companies like,Apple,Amazon,and Microsoft to name a few,and what they IPOed at,and then became,but Zelira may very well join the ranks of such tells.

[dhbuzz]

Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia

PR Newswire•February 18, 2020


- 23 chronic insomnia patients treated with ZLT-101, Zelira's proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index scores compared to placebo
- ZLT-101 therapy was well tolerated, with no serious adverse events reported
- Positive trial results an important milestone for Zelira
- Poised to launch world's first clinically validated medicinal cannabis product for insomnia in 2020
- Expands Zelira's product portfolio alongside the HOPE™ product range
PERTH, Australia, Feb. 18, 2020 /PRNewswire/ --
Teleconference 11am (AEDT) today with
Osagie Imasogie, Zelira Chairman
and Dr Richard Hopkins, Managing Director-ex USA
Toll free dial-in (Australia): 1800 908 299
Conference ID: 10004335
(more dial in options p4)
Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines, today announced positive Phase 1b/2a results confirming that ZLT-101 therapy achieved the primary endpoint of a statistically significant improvement in Insomnia Severity Index scores in patients diagnosed with chronic insomnia.
The Phase 1b/2a trial recruited 24 chronic insomnia patients, aged between 25-70. The study was a randomised, double-blind, cross-over design involving 14 nights of ZTL-101 and 14 nights of placebo, separated by a one-week washout period. All participants underwent a monitored sensitivity test to a mixture of ZTL-101 and placebo prior to commencing dosing. When dosing commenced each participant was able to take a single (0.5ml of 11.5mg total cannabinoids) or double (1 ml of 23mg total cannabinoids) dose of the medication, delivered sublingually, according to their symptoms.
Of the 23 participants who completed the protocol, 12 (52%) chose to increase the ZTL-101 medication from a single dose (0.5ml/11.5mg total cannabinoids) to double dose (1.0ml/23mg total cannabinoids) of ZTL-101 (as measured on the 14th night). Sixteen participants (69.5%) were taking a double dose (1.0ml) of the placebo on the 14th night.
Story continues
Start the conversation

[dhbuzz]

Stagering statistics on insomnia.

https://www.thegoodbody.com/insomnia-statistics/

[dhbuzz]

Current stats on Medical Marijuana in Penselvania look to be

positive and growing.

Exciting times ahead for Zelira IMO.

https://www.pghcitypaper.com/pittsburgh/the-results-are-in-heres-whos-using-medical-marijuana-in-pennsylvania-and-why/Content?oid=16564487

[dhbuzz]

This is the current list from Penselvanias Department Of Health,listing approved Medical Marijuana practitioners.


https://www.health.pa.gov/topics/Documents/Programs/Medical%20Marijuana/DOH%20Approved%20Practitioners.pdf

[dhbuzz]

Here is great evidence as to why I think Zelira is about to roll.

https://mjbizdaily.com/chart-pennsylvanias-medical-marijuana-market-set-become-one-countrys-biggest/

[dhbuzz]

Came across this summary of Zelira,it really goes into great detail

on the past,and the possible future here.IF it's been posted here previously my apologies...

It is really great dd for new eyes.

https://thegreenfund.com/zelira-therapeutics-latest-trends-and-insights

[dhbuzz]

By the end of March

I think you will be back above that .10

I suspect Zelira is going to be going on making new highs streak this year.

We shall see.

GL

[nonameface13]

Just wish I didn't buy at .10 :)

I'm looking for .50+ before selling...

[dhbuzz]

The deeper I dig into Zelira

the better it looks,from the Illera merge,to TerrAscend,and more.
The management,and pharma. connections Zelira has is impressive.Revenue is going to be rolling in from Pn.and La,and soon much more with the last results with insomnia trial.Also think Zelira would be being looked at by some very large phamas at this point as partnering or buy out.

[dhbuzz]

You bet,and thank you.

[dhbuzz]

I bought some this morning after finding it on intel,then I spent some time at their home web site,and just bought more.I see todays volume is way up from the avg too. A good sign,I think this boards going to start picking up,..

[nonameface13]

Thanks

[dhbuzz]

Here's the link...https://420intel.com/

[dhbuzz]

Found it looking at 420 intel cannabis web page,also just bought more,I think this starts moving soon.

GL

[nonameface13]

Curious - how'd you hear of Zelira? I'm from the US and invested for about 2 years... I do think by the end of this year, there should be movement in share price.

[dhbuzz]

Thanks for the interview nonameface13,very impressive team.

Looking forward to seeing how this -plays out.

[nonameface13]

Worth watching:

Need to give this company til end of year to prove itself...

[dhbuzz]

Just bought in,GL to all. eom

[dhbuzz]

https://420intel.com/articles/2020/02/21/positive-results-trial-cannabis-medicine-insomnia

[nonameface13]

https://qz.com/1796866/are-cannabinoids-a-good-sleep-aid/

[Renee]

Zelda Theraputics Ltd. changed to Zelira Therapeutics Ltd.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[nonameface13]

Zelda’s Phase II Insomnia Clinical Trial Fully Enrolled

https://clients3.weblink.com.au/pdf/ZLD/02169989.pdf

[nonameface13]

Read this Q/A from the co. - https://clients3.weblink.com.au/pdf/ZLD/02159322.pdf

[nonameface13]

New Cannabis Ventures -- Publicly-Traded Australian Company Zelda Therapeutics to Acquire American Cannabis Company Ilera Therapeutics

https://www.newcannabisventures.com/publicly-traded-australian-company-zelda-therapeutics-to-acquire-american-cannabis-company-ilera-therapeutics/

[nonameface13]

If there's a sell-off, it's because $ can be reinvested elsewhere til things take off later this year/next yr.

I just listened to the virtual conf. call... a question of mine was answered by both CEOs with regard to why ZLDAF is 'giving up' so much of their value... in short: a non-revenue generating co. will begin generating revenue next year... with practical access to US market, and then some... and a series of performance measures must be met...

We begin in PA, and then move throughout the nation (aside from our intl footprint)...

Unfortunately, little more patience - but the model is proven... Ilera Healthcare itself being sold to Terrascend for 245 mil or thereabout!

Real companies... real profits... let's do this... little more patience...

[Gettys_Burg]

Anyone have any thoughts on why this is causing such a sell off? I've read through it, seems like a positive move all around.

[Golden Cross]

Nice news... $ZLDAF

[nanook2]

Zelda to buy out Ilera. Deal just announced on twitter. New company will be Zelira

[nonameface13]

Perhaps Ilera Healthcare will take us over?

[nonameface13]

Trading Halt - Woohoo!

https://clients3.weblink.com.au/pdf/ZLD/02156493.pdf

[nanook2]

Terrascend just bought Ilera. This helps Zelda

[nonameface13]

Autism Observational Study Results and Next Steps
https://clients3.weblink.com.au/pdf/ZLD/02136667.pdf

[nonameface13]

Zelda Therapeutics Medical Marijuana and Autism Consensus Symposium 2019 in Philly/USA
https://www.eventbrite.com/e/zelda-therapeutics-medical-marijuana-and-autism-consensus-symposium-2019-registration-65253009508

Anyone attending?

[nonameface13]

Link to an active ZLDAF forum board... https://hotcopper.com.au/asx/zld/

https://hotcopper.com.au/asx/zld/

[nanook2]

Yep. I love this company.

[Gettys_Burg]

Lots of interesting things happening in the next year here! Check out their website.
Insomnia trials are moving along, just approved phase one for opioid addiction treatment and are already working with children's hospital of Philly in USA on autism treatment.

[nanook2]

Yummy

[nanook2]

This will launch before year end

[nonameface13]

Mara Gordon/TEDx - Cannabis: Separating the Science from the Hype

[nonameface13]

30 April 2019 - MARCH 2019 QUARTERLY REPORT

https://clients3.weblink.com.au/pdf/ZLD/02100124.pdf

[nonameface13]

Zelda Secures Australian Patent For Novel Prognostic Marker For Breast Cancer

Zelda awarded patent for a novel prognostic biomarker for breast cancer
Builds on Zelda’s world-class intellectual property portfolio for medicinal cannabis and cancer therapy
Prognostic marker helps predict patient survival and the probability of disease recurrence
Complements Zelda’s ongoing programmes to develop cannabis-based therapies for cancer
Patent provides protection until 2038

Zelda Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF): is pleased to announce the grant of a new patent in Australia covering a novel method to predict patient disease-free survival. The patent provides protection until 2038.

The patent (AU2017346940A) entitled “Prognostic method and kits useful in said method” details a method for detecting levels of expression of a novel receptor complex containing HER2 and CB2. HER2 is a well-recognised marker of aggressive breast cancer while CB2 is a key receptor in the endocannabinoid system. Together they form a novel receptor complex that represents a prognostic marker for HER2 positive breast cancer.

Zelda’s Managing Director, Dr Richard Hopkins commented “We’re delighted with the allowance of this patent, which supports Zelda’s strategy of building a world-class intellectual property portfolio and the development of cannabis- based products. Further news is expected as this patent family progresses through the international examination phase.

I’d also like to acknowledge the work of Professor Cristina Sanchez and her team who generated the data that supported this patent. This work was recently published in the prestigious peer-reviewed Proceedings of the National Academy of Sciences. This outcome highlights the benefit of Zelda’s approach of partnering with world-leading cannabis researchers.

Importantly, Professor Sanchez’s discovery of a novel prognostic biomarker, will complement our ongoing efforts develop to cannabis-based medicines to treat breast cancer."

Tim Slate
Company Secretary

[Gettys_Burg]

Waiting for one of my other stocks to climb a bit more, then I'm parking it here for another 100k shares. This is primed for a run in spring 2019.

[bigideaportugal]

A lot of people are getting margin calls. I had several friends of mine call me over the past two days asking which stocks they should liquidate. One of them said Zelda is down 30% since I bought, maybe sell that one. So you have ALOT of that going on. In the meantime, I added 55,000 more at my lowest price. .035